These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27943163)

  • 1. Atypical femoral fracture after receiving antiresorptive drugs in breast cancer patients with bone metastasis.
    Ota S; Inoue R; Shiozaki T; Yamamoto Y; Hashimoto N; Takeda O; Yoshikawa K; Ito J; Ishibashi Y
    Breast Cancer; 2017 Jul; 24(4):601-607. PubMed ID: 27943163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective Review of Atypical Femoral Fracture in Metastatic Bone Disease Patients Receiving Denosumab Therapy.
    Yang SP; Kim TW; Boland PJ; Farooki A
    Oncologist; 2017 Apr; 22(4):438-444. PubMed ID: 28275116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical Femoral Fractures (AFF) from Bone Remodeling Agents in Patients with Cancer.
    Kordoni M; Rigakos G; Kim YHM; Kaklamanis L; Nikolatou-Galitis O; Hadjiyassemi L; Labropoulos S; Razis E
    Anticancer Res; 2018 Nov; 38(11):6439-6444. PubMed ID: 30396969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impending Atypical Femoral Fracture in Patients With Medullary Thyroid Cancer With Skeletal Metastasis Treated With Long-term Bisphosphonate and Denosumab.
    Koizumi M; Gokita T; Toda K
    Clin Nucl Med; 2017 Jun; 42(6):463-464. PubMed ID: 28240655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review.
    Takahashi M; Ozaki Y; Kizawa R; Masuda J; Sakamaki K; Kinowaki K; Umezu T; Kondoh C; Tanabe Y; Tamura N; Miura Y; Shigekawa T; Kawabata H; Baba N; Iguchi H; Takano T
    BMC Cancer; 2019 Oct; 19(1):980. PubMed ID: 31640606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lateral Cortical Thickening and Bone Heterogeneity of the Subtrochanteric Femur Measured With Quantitative CT as Indicators for Early Detection of Atypical Femoral Fractures in Long-Term Bisphosphonate Users.
    Lee SH; Lee YH; Suh JS
    AJR Am J Roentgenol; 2017 Oct; 209(4):867-873. PubMed ID: 28796551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impending Atypical Femoral Fracture in a Patient of Breast Cancer With Bone Metastases Receiving Long-term Denosumab.
    Sugihara T; Koizumi M; Hayakawa K; Ito Y; Sata N
    Clin Nucl Med; 2018 May; 43(5):365-366. PubMed ID: 29517548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical femoral fracture associated with bone-modifying agent for bone metastasis of breast cancer: A report of two cases.
    Tateiwa D; Outani H; Iwasa S; Imura Y; Tanaka T; Oshima K; Naka N; Araki N
    J Orthop Surg (Hong Kong); 2017; 25(3):2309499017727916. PubMed ID: 28844196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical femoral fracture in a bisphosphonate-naïve patient on denosumab for osteoporosis.
    Kumar S; Chang R; Reyes M; Diamond T
    Arch Osteoporos; 2022 Oct; 17(1):131. PubMed ID: 36180610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates.
    Sato H; Kondo N; Wada Y; Nakatsue T; Iguchi S; Fujisawa J; Kazama JJ; Kuroda T; Nakano M; Endo N; Narita I
    Osteoporos Int; 2016 Mar; 27(3):1217-1225. PubMed ID: 26519417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative treatment of recurrent symptoms of an incomplete, atypical femoral fracture associated with glucocorticoid, bisphosphonate, and denosumab therapy in a patient with chronic obstructive pulmonary disease.
    Lai KH; Chiang CY; Yang RS; Yang KC; Wu CC
    Acta Clin Belg; 2019 Oct; 74(5):370-374. PubMed ID: 30336748
    [No Abstract]   [Full Text] [Related]  

  • 12. Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review.
    Selga J; Nuñez JH; Minguell J; Lalanza M; Garrido M
    Osteoporos Int; 2016 Feb; 27(2):827-32. PubMed ID: 26501556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates.
    Sato H; Kondo N; Nakatsue T; Wada Y; Fujisawa J; Kazama JJ; Kuroda T; Suzuki Y; Nakano M; Endo N; Narita I
    Osteoporos Int; 2017 Aug; 28(8):2367-2376. PubMed ID: 28409215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical Femoral Fractures : Three Cases And A Review Of Literature.
    Van Lieshout M; Putzeys G; Goemaere S; Van Der Straeten C; Audenaert E
    Acta Orthop Belg; 2017 Dec; 83(4):558-567. PubMed ID: 30423662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate-related atypical femoral fracture with bone metastasis of breast cancer: case report and review.
    Hayashi K; Aono M; Shintani K; Kazuki K
    Anticancer Res; 2014 Mar; 34(3):1245-9. PubMed ID: 24596367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proposal for an atypical femur fracture treatment and prevention clinical practice guideline.
    Dell R; Greene D
    Osteoporos Int; 2018 Jun; 29(6):1277-1283. PubMed ID: 29675745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiresorptive agents' bone-protective and adjuvant effects in postmenopausal women with early breast cancer.
    Chukir T; Liu Y; Farooki A
    Br J Clin Pharmacol; 2019 Jun; 85(6):1125-1135. PubMed ID: 30536446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy.
    Chang ST; Tenforde AS; Grimsrud CD; O'Ryan FS; Gonzalez JR; Baer DM; Chandra M; Lo JC
    Bone; 2012 Sep; 51(3):524-7. PubMed ID: 22634175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical tibial fracture in breast cancer patient with bone metastasis receiving denosumab therapy: a case report and review of the literature.
    Yanagisawa Y; Suzuki H; Gamada H; Yamazaki M
    J Med Case Rep; 2023 Jun; 17(1):257. PubMed ID: 37340320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry.
    Hagen JE; Miller AN; Ott SM; Gardner M; Morshed S; Jeray K; Alton TB; Ren D; Abblitt WP; Krieg JC
    J Bone Joint Surg Am; 2014 Nov; 96(22):1905-9. PubMed ID: 25410509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.